Blood Lithium Levels and Suicidal Events in People With Mood Disorders
Measures basal lithium in blood of adults with depression, bipolar disorder or suicidal behavior.
Plain-language title generated from the registry record
Registry title: Basal Plasma Lithium Levels and Suicidal Events
Key facts
- Where
- Montpellier, FranceSee the site
Where in France
- CHU MontpellierMontpellier, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Montpellier
- Trial code
- NCT05409794
- Record updated
- 9 August 2024
- Original description
Suicidal behavior is a major public health issue and there are currently no specific treatments for it.Read full original descriptionShow less
Basal Plasma Lithium Levels and Suicidal Events (LIPS)
Suicidal behavior is a major public health issue and there are currently no specific treatments for it.
However, lithium, the reference treatment for bipolar disorder, have been shown to be effective in preventing suicidal risk.
Apart from drug treatments, lithium is present in our environment and its levels varies from one individual to another, depending, especially, on diet.
Knowing that patients with a mood disorder generally have a poor lifestyle and a less rich and varied diet than the general population, variations in basal lithium levels can be expected in these patients.
Inclusion: 18 years old or over; Current major depressive episode according to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) criteria; No lithium-based treatment over the last 12 months; For suicide attempters/ideations only : suicidal event over the last 12 months; For affective controls only : no suicidal event over the last 12 months.
Exclusion: Lifetime diagnosis of schizoaffective disorder, schizophrenia or psychosis; Pregnancy or breastfeeding; Deprivation of freedom (by judicial or administrative decision); Legal protection measure (guardianship or curators); Inability to understand experimental procedures; No affiliation to the French National Social Security System; No consent to participate in the study.